Biosimilar Development Criteria
30 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary role of the Cε3 domain in IgE's interaction with its receptors?

  • Initiating the allergic cascade
  • Enabling the interaction with high-affinity receptors (correct)
  • Forming trimers with IgE molecules
  • Preventing the binding of complement

What is the effect of omalizumab binding to IgE on the allergic cascade?

  • It disrupts the allergic cascade (correct)
  • It amplifies the allergic response
  • It has no impact on the allergic cascade
  • It increases the production of IgE

What is the composition of the immune complexes formed by the binding of omalizumab to IgE?

  • Membrane-bound tetramers
  • Soluble trimeric or hexameric complexes (correct)
  • Insoluble monomers
  • Soluble dimers

Which cell types primarily express the high-affinity receptors (FcεRI) and low-affinity receptors (FcεRII/CD23) for IgE?

<p>Eosinophils, basophils, and mast cells (C)</p> Signup and view all the answers

What is the reason for the stability of IgE/omalizumab aggregates?

<p>The high affinity of omalizumab for IgE (D)</p> Signup and view all the answers

What is the consequence of the stability of IgE/omalizumab aggregates?

<p>They are easily removable by the mononuclear phagocytic system (C)</p> Signup and view all the answers

What is a major advantage of hybridoma technology in antibody production?

<p>It allows for the production of highly pure and specific antibodies. (D)</p> Signup and view all the answers

What is the primary function of PCSK9 in the liver?

<p>To bind to low-density lipoprotein (LDL) receptors, facilitating their degradation. (D)</p> Signup and view all the answers

What is the result of Evolocumab binding to PCSK9?

<p>An increase in LDL receptors on the liver surface, enhancing the removal of LDL-C from the blood. (B)</p> Signup and view all the answers

What is the primary mechanism of action of Evolocumab?

<p>It binds to PCSK9, inhibiting its ability to bind to LDL receptors. (B)</p> Signup and view all the answers

What is the class of antibody that Evolocumab belongs to?

<p>Immunoglobulin G2 (IgG2) lambda. (B)</p> Signup and view all the answers

What is the primary indication for Evolocumab therapy?

<p>Patients with conditions like familial hypercholesterolemia or those requiring additional LDL-C lowering beyond what can be achieved with diet and statin therapy alone. (D)</p> Signup and view all the answers

What is the primary influence of omalizumab's glycosylation on its pharmacokinetics?

<p>Influencing its distribution and metabolism (A)</p> Signup and view all the answers

What is the characteristic of the molecular structure of IgE?

<p>Comprising two identical light chains with a variable and a constant domain (B)</p> Signup and view all the answers

What is the primary function of the variable fragments (Fab) of IgE?

<p>Binding to specific antigens (B)</p> Signup and view all the answers

What is the implication of omalizumab's glycosylation on its therapeutic efficacy and safety?

<p>It requires careful consideration during its development and clinical evaluation (C)</p> Signup and view all the answers

What is the characteristic of the heavy chains of IgE?

<p>Including a variable portion and a constant fragment (A)</p> Signup and view all the answers

What is the primary binding site of the constant region (Fc) of IgE?

<p>IgE receptors (A)</p> Signup and view all the answers

What is the primary goal of the abbreviated pathway for FDA approval of biosimilars?

<p>Demonstrating biosimilarity between the proposed biosimilar and its reference product (C)</p> Signup and view all the answers

What type of studies are required to validate the similar safety and effectiveness of both the biosimilar and the reference product?

<p>Pharmacokinetic and pharmacodynamic comparability studies (B)</p> Signup and view all the answers

What is the primary purpose of nonclinical trials in the development of biosimilars?

<p>To assess the safety and efficacy of the biosimilar in vivo (D)</p> Signup and view all the answers

What is the significance of structural and functional similarity in the development of biosimilars?

<p>It confirms the biosimilar closely resembles the reference product in both structure and function (B)</p> Signup and view all the answers

What is the primary advantage of the FDA's abbreviated pathway for biosimilar approval?

<p>It reduces the time and cost of development without compromising safety and effectiveness (A)</p> Signup and view all the answers

What is the primary focus of comparative clinical trials in the development of biosimilars?

<p>To verify the clinical similarity between the biosimilar and the reference product (A)</p> Signup and view all the answers

What is the ranking of the binding ability to biotinylated rCD28/Fc among TGN1412, F(ab’)2, and Fab fragment?

<p>TGN1412 &gt; F(ab’)2 &gt; Fab (B)</p> Signup and view all the answers

Which subclass of IgG showed brighter staining of lymphocytes than TGN1412 and IgG4 using Flow cytometry?

<p>IgG2 (C)</p> Signup and view all the answers

Which of the following Fcγ receptors showed a different binding pattern compared to the others?

<p>NIB(28SA)-G2 (B)</p> Signup and view all the answers

What is the optimal response of immobilized TGN1412 in terms of cytokine release and cell proliferation?

<p>At a specific mAb concentration (D)</p> Signup and view all the answers

Which of the following IgG subclasses showed the highest maximum response in terms of cytokine release?

<p>IgG2 (D)</p> Signup and view all the answers

What is the difference in the response pattern of F(ab’)2 fragments compared to TGN1412?

<p>F(ab’)2 showed lower cytokine release at low doses but increasing responses at higher doses (C)</p> Signup and view all the answers

More Like This

Use Quizgecko on...
Browser
Browser